| AURKA (AurA) | Aur | Other | 2c6e | A | | n-{5-[(7-{[(2s)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}-6-methoxyquinazolin-4-yl)amino]pyrimidin-2-yl}benzamide | Human | 1989 | 0.41 | |
| EGFR | EGFR | TK | 4hjo | A | | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 835 | 1.00 | |
| MERTK (MER) | Axl | TK | 7avy | A | | n-(2-(2-cyclopropylethoxy)pyrimidin-5-yl)-7-methoxy-6-(piperidin-4-ylmethoxy)quinazolin-4-amine | Human | 13369 | 0.40 | |
| EGFR | EGFR | TK | 3ug2 | A | A | gefitinib | Human | 898 | 0.42 | |
| GAK | NAK | Other | 5y80 | A | A | gefitinib | Human | 10329 | 0.42 | |
| GAK | NAK | Other | 5y7z | A | | gefitinib | Human | 10332 | 0.42 | |
| CDK2 | CDK | CMGC | 1di8 | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 4577 | 0.55 | |
| GAK | NAK | Other | 5y7z | B | | gefitinib | Human | 10331 | 0.42 | |
| RIPK2 | RIPK | TKL | 6rn8 | B | | 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethyl dihydrogen phosphate | Human | 11431 | 0.40 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3pe2 | A | B | 5-[(3-ethynylphenyl)amino]pyrimido[4,5-c]quinoline-8-carboxylic acid | Human | 5519 | 0.43 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3pe2 | A | A | 5-[(3-ethynylphenyl)amino]pyrimido[4,5-c]quinoline-8-carboxylic acid | Human | 5508 | 0.43 | |
| EGFR | EGFR | TK | 3ug2 | A | B | gefitinib | Human | 819 | 0.42 | |
| EGFR | EGFR | TK | 2ito | A | | gefitinib | Human | 783 | 0.42 | |
| EGFR | EGFR | TK | 2itz | A | | gefitinib | Human | 789 | 0.42 | |
| AURKA (AurA) | Aur | Other | 2c6e | B | | n-{5-[(7-{[(2s)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}-6-methoxyquinazolin-4-yl)amino]pyrimidin-2-yl}benzamide | Human | 2046 | 0.41 | |
| EGFR | EGFR | TK | 1m17 | A | A | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 873 | 1.00 | |
| GAK | NAK | Other | 5y80 | A | B | gefitinib | Human | 10330 | 0.42 | |
| RIPK2 | RIPK | TKL | 6rn8 | A | | 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethyl dihydrogen phosphate | Human | 11434 | 0.40 | |
| ABL1 | Abl | TK | 8ssn | A | | 6,7-dimethoxy-n-(4-phenoxyphenyl)quinazolin-4-amine | Human | 14878 | 0.47 | |
| MAPK14 (p38a) | MAPK | CMGC | 1di9 | A | | 4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline | Human | 5251 | 0.51 | |
| TTBK1 | TTBK | CK1 | 4btk | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 771 | 0.55 | |
| EGFR | EGFR | TK | 4i22 | A | | gefitinib | Human | 823 | 0.42 | |
| EGFR | EGFR | TK | 4wkq | A | A | gefitinib | Human | 889 | 0.42 | |
| EGFR | EGFR | TK | 4wkq | A | B | gefitinib | Human | 837 | 0.42 | |
| EGFR | EGFR | TK | 1m17 | A | B | [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine | Human | 905 | 1.00 | |
| EGFR | EGFR | TK | 2ity | A | | gefitinib | Human | 790 | 0.42 | |
| TTBK2 | TTBK | CK1 | 6u0k | B | A | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12049 | 0.55 | |
| TTBK2 | TTBK | CK1 | 6u0k | A | A | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12046 | 0.55 | |
| TTBK2 | TTBK | CK1 | 6u0k | B | B | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12047 | 0.55 | |
| TTBK2 | TTBK | CK1 | 6u0k | A | B | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 12048 | 0.55 | |
| RET | Ret | TK | 5amn | A | | 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline | Human | 6412 | 0.55 | |